US futures faltered on Tuesday as investors sought to assess the impact of stopping Johnson & Johnson vaccines and rising inflation.
S&P 500 futures fluctuated between gains and losses. Monday’s broad market index is close to its recent record, which closed the high. Future Nasdaq-100 technologies have increased by 0.5%.
Health officials have recommended a break in the use of Johnson & Johnson vaccine following reports of blood clotting. The Food and Drug Administration and the Centers for Disease Control and Prevention are examining data involving six reported cases of coagulation.
“It means that the rate at which you reach the herd’s immunity is low and will take longer to reopen the economy,” said Sebastien Galy, a macro strategist at Nordea Asset Management.
New data also showed that US consumer prices rose sharply in March as the economic recovery picked up, partly reflecting higher petrol prices. The Department of Labor reported that the consumer price index rose 2.6% in the year ended March.